Clene Nanomedicine - CLNN Net earnings per one share for the last twelve months

Clene Inc (CLNN) - corporate logo

Clene Inc. (CLNN) management enjoys the support of long-term shareholders, focusing efforts on the certification of neuropreparations. The business relies on an innovative gold-particle suspension that creates an energy shield for neurons in ALS patients. This chart of EPS TTM, which stands at 30.80, complements the analysis. The future of Clene Inc. (CLNN) depends on clinical test results and the ability of regulators to approve the commercial launch of the therapy.

Clene Inc - CLNN Net earnings per share (EPS TTM) (period 02/11/2024 - 11/15/2026)

Clene - analytical breakdowns and key metrics (CLNN)

- share price and consensus valuation forecast:
Share Price clene.com|CLNN - Analyst Consensus Forecast
- issuer market value details:
Market Value Clene|CLNN - Real Price to Acquire Entire Company
- company book value details:
Accounting Value of a Share Clene|CLNN - Book Capitalization|Market Capitalization to Book Value clene.com|CLNN - Aggregate Company Assets
- debt burden and liquidity indicators:
Debt to Equity Ratio Clene Inc.|CLNN - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Clene Inc|CLNN - Company Total Debt|Debts to Net Assets Clene Nanomedicine|CLNN - Company Long-Term Debts|Company Current Liabilities Clene|Quick Liquidity clene.com
- financial results and valuation multiples details:
CLNN - Company Net Income|Net Profit Forecast Clene Inc.|CLNN - Price to Earnings Ratio|Price to Future Earnings Ratio Clene|CLNN - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation Clene Nanomedicine|CLNN - Operating profit EBITDA|Net earnings per one share for the last twelve months Clene|CLNN - Net earnings per share for the last 12 months|Quarterly EPS earnings growth clene.com|CLNN - Earnings per share growth in current year|Expected earnings per share trend next year Clene Inc.
- sales and revenue indicators:
CLNN - Company Revenue|Company Expected Sales Volume clene.com|CLNN - P/S Multiple|Forward Price-to-Revenue Multiple Clene Inc.|CLNN - Sales Growth YoY (Last Twelve Months)
Fundamental valuation:CLNN (Clene Inc)
Finished products of clene.com

This indicator measures the annual growth of net income per share over the last twelve months, allowing for an assessment of the business's actual scaling pace without market noise. Analyzing the trend of the EPS YoY TTM percentage change serves as a portfolio stress test, confirming the potential of Clene Inc. (CLNN) to monetize unique nanotechnology for ALS treatment amid completely inelastic demand.

Competitor analysis for Clene Inc.

Net earnings per share for the trailing year Biogen (BIIB)|neurocrine.com (NBIX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Regencell|AXSM (Axsome) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) ACADIA Pharmaceuticals Inc.|Earnings per share for the last twelve months Xenon Pharmaceuticals (XENE)|VKTX (Viking Pharma) - Earnings per share for the trailing year|Earnings per share for the last twelve months Supernus Corp SUPN|Earnings per share for the last four quarters CPRX (Catalyst Pharmaceuticals)|Denali Therapeutics - Net earnings per share (EPS TTM)|HRMY: Earnings per share for the last twelve months|Biohaven (BHVN) - Earnings per share for the last twelve months|Amylyx Pharmaceuticals Inc (AMLX) - Net earnings per share (EPS TTM)|TRVI (Trevi Therapeutics Inc) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Praxis Medicines (PRAX)|Net earnings per share for the last 12 months AVXL (Anavex Life Sciences)|Net earnings per share for the last 12 months CeriBell CBLL|Earnings per share for the last twelve months Prothena Biosciences PRTA|Net earnings per share (EPS TTM) Alector, Inc. ALEC|ANNX - Earnings per share for the last twelve months|OMER - Net earnings per share (EPS TTM)|Neurogene (NGNE) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months AC Immune SA (ACIU)|Net earnings per share for the last 12 months VYGR|Net earnings per share (EPS TTM) Neumora Therapeutics Inc|Earnings per share for the last twelve months scilexholding.com (SCLX)|Net earnings per share for the last four quarters Tevogen Bio Inc.|Earnings per share for the last twelve months Alpha Cognition Inc. ACOG|Net earnings per share (EPS TTM) Cognition Therapeutics CGTX|IKT: Net earnings per share for the last 12 months|SAVA (Cassava Sciences) - Earnings per share for the last 12 months|Assertio Holdings, Inc. (ASRT) - Earnings per share for the last twelve months|Earnings per share for the last 12 months COYA|Earnings per share for the last twelve months Vistagen|Net earnings per share for the last 12 months Ovid Therapeutics (OVID)|Earnings per share for the last twelve months Acumen Pharmaceuticals Inc. (ABOS)|CRVO - Net earnings per one share for the last twelve months|Alterity Therapeutics Limited - Net earnings per share for the last 12 months|PEPG (PepGen Corp) - Earnings per one share for the last 12 months|JUNS - Earnings per share for the last twelve months|RLMD (relmada.com) - Earnings per share for the last 12 months|Annovis Bio Corporation (ANVS) - Earnings per share for the last twelve months|Grace Therapeutics Inc - Earnings per share for the trailing year|AIFF (Firefly Neuro) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months KLTO|Earnings per share for the last twelve months NeuroSense Therapeutics, Ltd. (NRSN)|Reviva Pharmaceuticals - Earnings per share for the last 12 months|MetaVia Inc - Net earnings per share for the last 12 months|NRXS: Earnings per share for the last 12 months|HSDT - Earnings per share for the last twelve months|Net earnings per share for the last four quarters passagebio.com PASG|NEUP (Neuphoria Therapeutics) - Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months minervaneurosciences.com (NERV)|ATHA (Athira Pharma Inc) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Addex Therapeutics, Ltd. ADXN|Net earnings per share (EPS TTM) ALZN|Net earnings per share for the last 12 months Cyclerion CYCN|Earnings per share for the last twelve months Protagenic Therapeutics Inc. PTIX|Net earnings per share for the last four quarters Pasithea (KTTA)|Cortigent Inc - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Avenue Therapeutics, Inc|BCLI (Brainstorm Cell Therapeutics, Inc.) - Net earnings per share for the last 12 months|Cara Therapeutics, Inc. (CARA) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Chromocell Therapeutics Corp|Net earnings per one share for the last twelve months eliemtx.com ELYM|Earnings per share for the last twelve months Intra-Cellular Therapies Inc. (ITCI)|Longboard Pharmaceuticals, Inc. - Earnings per share for the last 12 months|Marinus Pharmaceuticals Inc - Net earnings per share for the last 12 months|NKGen (NKGN) - Net earnings per one share for the last twelve months|NRBO - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months sagerx.com|SNPX: Net earnings per share (EPS TTM)|Trevena Inc. (TRVN) - Net earnings per share (EPS TTM)|VIGL (Vigil Neuroscience, Inc.) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months WENA (Anew Medical, Inc.)|Net earnings per share (EPS TTM) CERE